SCHEMBL5567564

SCHEMBL5567564

COc1nnc(-c2ccncc2)cc1-c1c(CO)c2ccccc2n1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
NR1H2 P55055 8/20 0.36
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36
TUBA1C Q9BQE3 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1751128 0.89 SQOR (0.37) SQORACACBACACACHRM2CHRM4
SCHEMBL1751863 0.79 NR1H2 (0.50) NR1H2NR1H3
SCHEMBL5567250 0.77 SQOR (0.43) SQORTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3425628 0.76 MAOB (0.39) NR1H2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1750924 0.76 NR1H2 (0.42) NR1H2NR1H3
SCHEMBL3422798 0.76 TTK (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3427584 0.72 CCNB2 (0.40) CHRM2CHRM4CHRM1CHRM3NR1H2
SCHEMBL1750157 0.72 NR1H2 (0.42) NR1H2NR1H3
SCHEMBL3425173 0.72 GPR119 (0.34) NR1H2NR1H3
SCHEMBL3425025 0.72 NR1H2 (0.39) NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751141-A1 NOVEL PYRIDAZINONE DERIVATIVES AS INHIBITORS OF CDK2 Aventis Pharma S.A. (FR) 2007-02-14 EP disclosed
WO-2005111019-A1 NOVEL PYRIDAZINONE DERIVATIVES AS INHIBITORS OF CDK2 AVENTIS PHARMA S.A. (FR) 2005-11-24 WO disclosed